Today At A Glance:

U.S. stocks closed lower on Wednesday, December 17, 2025, as renewed pressure in AI-linked megacaps weighed on sentiment and pulled the major indexes off their early footing. The weakness was most visible in large-cap tech and semis—Oracle and Broadcom were among the notable drags—while investors kept one eye on shifting expectations for the Fed’s next moves. Despite the down tape, there were pockets of strength in event-driven names, highlighted by Medline’s strong IPO debut and select “single-stock story” movers. Market breadth was negative overall, reinforcing that this was a risk-trim day rather than a simple sector rotation. The close leaves traders focused on whether the AI valuation unwind continues or stabilizes into the next session.

Today’s Index Performance

• Dow Jones Industrial Average (^DJI): The index opened today at 48,128.05 and closed today at 47,961.32, with the percentage change of -0.32%.
• S&P 500 (^GSPC): The index opened today at 6,808.43 and closed today at 6,730.58, with the percentage change of -1.02%.
• Nasdaq Composite (^IXIC): The index opened today at 23,135.61 and closed today at 22,767.23, with the percentage change of -1.49%.

Gainers Of Note:

• Mega Fortune Company Limited (MGRT) (+147.66%) — A small-cap IoT solutions provider; the move appears consistent with speculative microcap momentum and aggressive risk appetite in thin floats.
• Processa Pharmaceuticals (PCSA) (+94.34%) — A clinical-stage oncology biotech; shares surged on encouraging preliminary Phase 2 data for its next-generation cancer therapy approach in advanced/metastatic breast cancer.
• cbdMD, Inc. (YCBD) (+62.24%) — A consumer CBD/wellness products company; the stock ran on cannabis-policy speculation and unusually heavy trading tied to the broader “marijuana headline” theme.

Losers Of Note:

• Vistagen Therapeutics (VTGN) (-80.33%) — A biotech focused on neuroscience/anxiety indications; shares collapsed after it reported PALISADE-3 Phase 3 results that did not meet the primary endpoint for fasedienol in social anxiety disorder.
• Vision Marine Technologies (VMAR) (-45.74%) — An electric marine propulsion and boat retail/services name; the decline reflected a sharp reversal following prior speculative trading, with no single dominant new catalyst broadly cited in mainstream roundups.
• The Children’s Place (PLCE) (-37.01%) — A children’s apparel retailer; shares fell sharply after a weak quarterly update featuring pressured sales/gross margin and renewed concerns around execution and tariff/inventory headwinds.

Active Traders Of Note:

• NVIDIA (NVDA) — AI semiconductors; remained one of the most heavily traded names as the market continued to de-risk crowded AI exposure.
• Tesla (TSLA) — EVs/energy; high turnover followed a sharp pullback tied to regulatory pressure around Autopilot advertising and elevated options-driven flow.
• Broadcom (AVGO) — Semiconductors/infrastructure software; heavy volume tracked continued AI-compute spending debates and a broad semis downdraft during the session.

Looking Forward:

Wednesday’s close suggests investors are still quick to sell perceived “priced-for-perfection” AI exposure, so the next session may hinge on whether megacap tech stabilizes or extends the drawdown. If rate-cut expectations firm up on incoming macro data, that could cushion growth—but it will likely take more than one supportive datapoint to reverse today’s risk-off tone. For traders, watch follow-through in high-volume leaders (NVDA/TSLA/AVGO) and whether IPO strength (e.g., Medline) signals risk appetite is narrowing rather than disappearing.

THIS NEWSLETTER IS PARTNERED WITH ROBINHOOD.COM AND IS FINANCIALLY SPONSORED BY THAT SERVICE.

TO BEGIN YOUR INVESTMENT JOURNEY TODAY, USE THIS LINK TO SET UP YOUR ACCOUNT.